Skip to main content


Table 2 Actions proposed by the WHO Regional Committee for Africa [36]

From: Combating poor-quality anti-malarial medicines: a call to action

Prioritize the development of medical products regulation
Strengthen the coherence and performance of the medicines regulatory system (including dialogue among stakeholders)a
Adapt and use guidelines in line with WHO recommendations
Increase implementation of regulatory functions
Enhance the status of NMRAs
Institute sustainable mechanisms to effectively manage conflicts of interest
Strengthen inter-sectoral collaboration between relevant stakeholders
Ensure availability of qualified human resources for regulation of medical products
Ensure adequate and sustainable financing of the medicines regulatory system
Improve collaboration, coordination, and harmonization of medical products regulation
  1. aDefined as NMRAs, manufacturers, traders, consumers and other representatives of civil society, health professionals, researchers, police, customs, the judiciary, governments, and parliamentarians